Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter Study With an Open-Label Extension to Evaluate the Efficacy and Safety of Ravulizumab in Patients With Amyotrophic Lateral Sclerosis (ALS)
Kasarskis, Edward
(PI)
Neurology
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
10/20/20
→
6/15/22
Funding
Alexion Pharmaceuticals:
$40,542.00
View all
View less